Skip to main content

Adopting New Medical Technology (1994) / Chapter Skim
Currently Skimming:

7. BLUE CROSS AND BLUE SHIELD ASSOCIATION INITIATIVES IN TECHNOLOGY ASSESSMENT
Pages 96-100

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 96...
... nationwide. This chapter describes the BCBSA technology assessment program and a recent initiative to support clinical trials for breast cancer treatments.
From page 97...
... Below is presented a brief summary of the five technology assessment criteria used by the BCBSA to determine whether a technology improves health outcomes and can be recommended as eligible for coverage.
From page 98...
... Second, BCBSA appointed a new nineteen-member Medical Advisory Panel, of which the majority of members have no affiliation with Kaiser Permanente or the BCBS plans. Members are noted experts in technology assessment, research, and clinical areas and Dr.
From page 99...
... " The purpose of the demonstration project is to support randomized controlled clinical trials comparing the efficacy of HDC-ABMT with that of conventional chemotherapy in the treatment of advanced breast cancer with a poor prognosis. The clinical trials are sponsored by the National Cancer Institute, the Clinical Trials Cooperative Groups, and the Philadelphia Bone Marrow Transplant Group.
From page 100...
... FUTURE DIRECTIONS The Blue Cross and Blue Shield Association, the Blue Cross and Blue Shield plans, and all third-party payers are closely following the progress of the demons~ation project. It may serve as a model for how insurers can support clinical research for promising investigational treatments targeted to life-threatening or seriously disabling conditions.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.